Related Compounds
Compounds connected by the same goals, effects, or research topics.
We use privacy-friendly analytics. Read our privacy policy.
Compound Profile
Can be discussed as PCOS/metabolic evidence if site scope expands.
Use extra caution — Review before use if any apply: Limited Data. Details
Bottom line
Safety: Usually well tolerated; high doses can cause mild GI upset. Involve a clinician for a diagnosed condition.
On the evidence: Small randomized trials for panic and anxiety; effective doses are high.
Best for
Not ideal for
Consider instead: L-theanine — for acute, in-the-moment calm
Why not higher
Why not lower
Practical takeaway: Reasonable to try over several weeks for panic-type anxiety if you can tolerate the large dose. Not a fast-acting rescue tool.
Safety
Review before use if any apply: Limited Data.
Standard caution
Caution level: Standard. No specific caution categories were detected in the source record.
Useful signal, but study design, dose, and population still matter.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation · Insulin Sensitivity Improvement · Ovarian Function Signaling Support
Research maturity: Established research — main contexts: IP3 Pathway · Insulin Signaling
Safety boundary: Safety note available — Review before use if any apply: Limited Data.
This profile cites 1 human study.
Confidence estimate based on the design quality and consistency of published clinical trials.
Inositol has a limited evidence rating.
Evaluation of methodological rigor, population reach, and evidence alignment.
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
Filter by study class
Showing 3 of 3 studies.
What the evidence actually shows
This table contains 3 structured sources, including 2 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Greff et al. · Reproductive Biology and Endocrinology · 2023 Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | — | Source → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | Inositol improved selected biochemical/hyperandrogenism outcomes, with response varying by metabolic phenotype. | PubMed → |
Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | Some outcomes show benefit, but the umbrella review found no high-quality GRADE evidence; most evidence was low or very low certainty. | PubMed → |
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Inositol Works
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Condition guides
Continue exploring
Compounds connected by the same goals, effects, or research topics.
Botanicals connected by the same goals, effects, or research topics.
Deeper context, comparisons, and practical research paths.
Safety checks and cautions relevant to this decision.
Deeper context, comparisons, and practical research paths.
Compare side-by-side tradeoffs or verify active marker guidelines.
Free safety checklist
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Sourcing options
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
When sourcing Inositol, verify the label for:
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?